Pharmosa Biopharm Inc. (6875)
Market Closed
16 Oct, 05:30 AM
TWSE 
NT$
27. 95
+1.5
+5.6711%
NT$
- Market Cap
- P/E Ratio
1,000% Div Yield
289,127 Volume
- Eps
NT$ 26.45
Previous Close Want to track 6875 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pharmosa Biopharm Inc. (6875) Statistics
Valuation metrics
Market Cap -
Enterprise value 3.1B
Trailing P/E (ttm) -9.89
Forward P/E -
PEG ratio 0.19
Price/Sales (ttm) 65.34
Price/Book (mrq) 2.55
Enterprise Value/Revenue 57.99
Enterprise Value/EBITDA -9.03
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 380.63K
Average volume (90 days) 142.95K
Price summary
52-Week low 26.45
52-Week high 65
Beta -
50-Day moving average 31.8
200-Day moving average 35.14
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 511:500
Last split Date 10 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.58%
Operating margin -7.62%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.41
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.72
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.23
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 12.45%
Book value per share (mrq) 10.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
